Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 1429 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Medigene–Baader Bank: investor conference, 201609 supply service Medigene presents at Baader Investment Conference 2016 in Munich 2016-09-20
MorphoSys–Bank of America: investor conference, 201609 supply service MorphoSys presents at BAML Global Health Care Conference 2016 London 2016-09-15
Organobalance–Novo Group: investment, 201609 acquisition €na of Organobalance GmbH by Novozymes 2016-09-15
Mologen–SEVERAL: investment, 201609–201610 capital increase €13.6m 11.316m common shares at €1.2/share (raising no. of existing shares by up to 50%) 2016-09-13
MorphoSys–JPMorgan Chase: investor conference, 201609 supply service MorphoSys presents at JP Morgan London Small/Mid Cap Conference 2016 2016-09-13
PaxVax–Leukocare: drug formulation technology, 201609– license to SPS technology for one live viral vaccine product of PaxVax 2016-09-13
MorphoSys–Morgan Stanley: investor conference, 201609 supply service MorphoSys presents at Morgan Stanley Global Healthcare Conference NY 2016-09-12
MorphoSys–Goldman Sachs: investor conference, 201609 supply service MorphoSys presents at GS Annual Biotech Symposium in London 2016-09-09
Affimed–Wells Fargo: investor conference, 201609 supply service Affimed presents at Wells Fargo Healthcare Conference in Boston 2016-09-08
Bayer–Helmholtz: plant science, 201609– collab strategic research 5y phenotyping for products by Bayer CropScience + FZJ 2016-09-08
Affimed–Credit Suisse: investor conference, 201609 supply service Affimed presents at Credit Suisse Antibody Day 2016 in New York 2016-09-07
Curetis–Siemens: GEAR database, 201609 acquisition €na of ww rights to GEAR database + related IP + know-how by Curetis from STA 2016-09-07
Biomeva–Asahi Glass: investment, 201609 acquisition 100% of Biomeva GmbH by Asahi Glass 2016-09-06
Rigontec–Boehringer: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor BIVF 2016-09-06
Rigontec–Forbion: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor Forbion Capital Partners 2016-09-06
Rigontec–High-Tech Gründerfonds: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor HTGF 2016-09-06
Rigontec–MacDougall Biomedical Communications: public relations, 201609 service existent by MacDougall 2016-09-06
Rigontec–Mitsubishi Chemical: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor MP Healthcare 2016-09-06
Rigontec–North Rhine-Westphalia (govt): investment, 201609 financing round Series A 3rd + final closing totalling €15m w returning investor NRW.BANK 2016-09-06
Rigontec–SEVERAL: investment, 201609 financing round Series A 3rd + final closing €15m from existing investors 2016-09-06
Rigontec–Sunstone Capital: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor Sunstone Capital 2016-09-06
Rigontec–Wellington Partners: investment, 201609 financing round Series A 3rd + final closing totalling €15m incl returning investor Wellington 2016-09-06
DiViNe project–Merck (DE): vaccine purification technology, 201609– collab Merck is partner in Horizon 2020 project led by iBET 2016-09-01
Innovative Medicines Initiative–Lipotype: lipidomics, 201609– collab Lipotype is participant in RHAPYSODY project on type 2 diabetes 2016-09-01
Zinsser Analytic–Kohlberg Kravis Roberts: investment, 201609 acquisition of ILS Gmbh + Zinsser Analytic GmbH from Mr+Ms Zinsser by Gardner Denver 2016-09-01
Boehringer–Saniona: schizophrenia drugs, 201608– collab reserach €5m upfront + €85m milestones + royalties to identify compounds for schizophrenia 2016-08-29
Earlybird–SEVERAL: investment, 201608 first closing of Earlybird Health Tech Fund incl investors NRW.Bank + Generali + Miele + BMWE + Barmer GEK 2016-08-24
Ayoxxa–Märzhäuser: microplate reader, 201608 collab developm + contract manufacturing of Ayoxxa Reader AR01 by Märzhäuser 2016-08-22
Mologen–NN: business development services, 201608c– supply service to find outlicensing opportunities for lefitolimod 2016-08-11
Werfen–Protagen: biomarker, 201608– license semi-excl for use of BICD2 biomarker for diagnosis of systemic sclerosis to Inova Diagnostics 2016-08-11
Akvolution–High-Tech Gründerfonds: investment, 201608 financing round Series A incl returning investor HTGF 2016-08-04
Akvolution–SEVERAL: investment, 201608 financing round Series A from HTGF + VNG Innovation + Bamag + private investors 2016-08-04
Oncgnostics–SEVERAL: investment, 201608–201606 crowdfunding campaign €500k via Seedmatch platform 2016-08-04
Applied Micorarrays–Scienion: print/spotting technology, 201607– collab strategic partnership to support developm + production of IVD products 2016-07-28
Merck (DE)–Amoy Diagnostics: molecular diagnostics, 201607– collab developm liquid biopsy RAS biomarker CRC test based on ADx-SuperARMS for China 2016-07-28
Eurofins–Lablicate: mass spectrometry software, 201607 supply existent Eurofins is reference customer for OpenChrom s/w 2016-07-27
Symrise–Lablicate: mass spectrometry software, 201607 supply existent Symrise is reference customer for OpenChrom s/w 2016-07-27
Lophius–SEVERAL: investment, 201607 financing round €4.25m led by VRD GmbH + incl Bayern Kapital + Wolf Biotech + WIC GmbH 2016-07-26
Numares–Bavaria (govt): investment, 201607 financing round incl €2m from Wachstumsfonds Bayern managed by Bayern Kapital 2016-07-26
Numares–SEVERAL: investment, 201607 financing round incl €2m from Wachstumsfonds Bayern managed by Bayern Kapital 2016-07-26
InflaRx–SEVERAL: investment, 201607 financing round Series C €31m incl new investor Staidson Hongkong Investment Co Ltd 2016-07-21
Molecular Health–Akampion: public relations, 201607 service existent EMEA media + investor relations by Akampion 2016-07-21
ViroCyt–Sartorius: investment, 201607 acquisition valueing ViroCyt at $16m 2016-07-15
Boehringer–Univ Dundee: PROTAC technology, 201607– collab developm of PROTACs 2016-07-14
Bayer–X-Chem: small-molecule drug discovery, 2016– collab extension of access to DEX technology up to $528m in upfront + r+d funding + milestones 2016-07-12
AMSilk–Kirchhoff Consult: public relations, 201607 service existent by Kirchhoff Consult AG 2016-07-11
AMSilk–SEVERAL: investment, 201607 financing round with existing investors MIG Fonds + AT Newtec 2016-07-11
Antibiotic Research UK–Evotec: drug discovery services, 201607– collab research €na to discovery antibiotic resistance breakers (ARBs) 2016-07-11
CryoTherapeutics–Creathor Venture: investment, 201607 financing round Series B totalling €5.2m incl lead investor Creathor Venture 2016-07-07
CryoTherapeutics–Germany (govt): investment, 201607 financing round Series B totalling €5.2m incl returning co-investor KfW 2016-07-07
CryoTherapeutics–Getz Brothers: investment, 201607 financing round Series B totalling €5.2m incl returning co-investor Getz Brothers 2016-07-07
CryoTherapeutics–High-Tech Gründerfonds: investment, 201607 financing round Series B totalling €5.2m incl returning co-investor HTGF 2016-07-07
CryoTherapeutics–North Rhine-Westphalia (govt): investment, 201607 financing round Series B totalling €5.2m incl returning co-investor NRW.Bank 2016-07-07
CryoTherapeutics–Peppermint: investment, 201607 financing round Series B totalling €5.2m incl returning co-investor Peppermint CBF 2016-07-07
CryoTherapeutics–SEVERAL: investment, 201607 financing round Series B €5.2m led by Creathor incl NRW.Bank + Peppermint CBF + HTGF et al 2016-07-07
Evotec–MIT: CRISPR technology, 201607– research tool license non-excl to CRISPR-Cas9 gene editing technology from Broad Institute 2016-07-06
kSep Systems–Sartorius: investment, 201607 acquisition $28m of kSep Holdings Inc by SSB 2016-07-06
Global Bioenergies–Germany (govt): grant, 201607–201709 BMBF grant €400k for developm of renewable gasoline additives 2016-07-01
Evotec–Ellersbrook: investment, 201606– Ellersbrook will invest in Evotec’s internal TargetNASH programme 2016-06-29
Bruker Corp–Univ Greifswald: NMR spectroscopy, –201606 collab developm of B.I.-LISA module based on AVANCE IVDr platform w Prof Nauck 2016-06-28
Evotec–Genedata: bioinformatics, 201606– supply license Evotec using Genedata Screener now in HTS + HCS 2016-06-28
IntelliCyt–Sartorius: investment, 201606 acquisition for $90m in cash incl $5m in future tax savings 2016-06-28
Probiodrug–Demy-Colton: business conference, 201606 supply service Probiodrug AG to attend Biotech CEO Summit Europe 2016-06-28
Cosmo Pharmaceuticals–Paion: remimazolam, 201606– license excl €10m upfront + €42.5m milestones + royalties for developm + commercialisation in US 2016-06-24
Paion–Cosmo Pharmaceuticals: investment, 201606 investment as part of license agreem w Cosmo becoming largest shareholder holding 9.09% 2016-06-24
Allecra Therapeutics–Delos Capital: investment, 201606 financing round Series B totalling €22m incl new + lead investor Delos Capital 2016-06-16
Allecra Therapeutics–Forbion: investment, 201606 financing round Series B totalling €22m incl returning co-investor FCF II Co-Invest I fund 2016-06-16
Allecra Therapeutics–SEVERAL: investment, 201606 financing round Series B €22m led by new investor Delos Capital 2016-06-16
Sony–Stratec: investment, 201606–201607 acquisition €30m 100% of Sony DADC BioSciences business by Stratec 2016-06-08
Affimed–Leucadia: investor conference, 201606 supply service Affimed presents at Jefferies 2016 Global Healthcare Conference NY 2016-06-07
Apogenix–Leucadia: investor conference, 201606 supply service Apogenix presents at Jefferies Healthcare Conference in New York 2016-06-07
Probiodrug–Leucadia: investor conference, 201606 supply service Probiodrug presents at Jefferies Healthcare Conference in New York 2016-06-07
Dr. Falk Pharma–Cosmo Pharmaceuticals: antibiotic, 201606– license existent for Rifamycin SV MMX for EU + Australia 2016-06-06
Max Planck–Bruker Corp: mass spectrometer, 201606 supply existent MPI for Biophysics Ffm early user of rapifleX MALDI-TOF/TOF system 2016-06-06
Grünenthal–AstraZeneca: lesinurad, 201606– license excl for Europe + Latin America to Zurampic + fixed dose combi of lesinurad + allopurinol 2016-06-02
Boehringer–Harvard Univ: drug research, 201606– collab research alliance 3y €na for novel treatments for severe fibrotic diseases 2016-06-01
Emperra–Germany (govt): business development, 201606– supply service support in US with German Accelerator Life Sciences programme 2016-06-01
ERS Genomics–MacDougall Biomedical Communications: public relations, 201606 service existent by MacDougall 2016-06-01
TxCell–Univ Lübeck: cell therapy, 201606– collab €na developm of CAR-Treg cells to treat bullous pemphigoid with LIED 2016-06-01
Hyglos–Mérieux: investment, 201605 acquisition 100% of Hyglos by bioMérieux for €24m phased over 3 years 2016-05-31
Link Health–4SC: cancer drug, 201605– collab license + developm partnership for 4SC-205 in Greater China 2016-05-31
Sividon Diagnostics–Myriad: investment, 201605 acquisition for €35m upfront + €15m milestones 2016-05-31
Qiagen–Therawis: molecular companion diagnostics, 201605– license + co-developm predictive oncology tests w initial project using PITX2 assay 2016-05-25
Axela–Scienion: print/spotting technology, 201605– collab developm + marketing of production systems + services for diagnostics + research 2016-05-24
Epigenomics–SEVERAL: investment, 201605 private placement €6.8m w 1.436m new shares at €4.76/share led by BioChain (55%) 2016-05-24
Evotec–Berenberg: investor conference, 201605 supply service Evotec presents at Berenberg European Conference USA in Tarrytown 2016-05-24
Molecular Partners–UBS: investor conference, 201605 supply service Molecular Partners presents at UBS Global Healthcare Conference NY 2016-05-24
MorphoSys–Univ Texas: antibody cancer drug, 201605– collab strategic alliance r+d using Ylanthia technology with MD Anderson ORBIT unit 2016-05-24
Xenikos–MC Services: public relations, 201605 service existent for Xenikos BV by MC Services AG Düsseldorf 2016-05-24
Affimed–UBS: investor conference, 201605 supply service Affimed presents at UBS Global Healthcare Conference NY 2016-05-23
Boehringer–BioMed X: pharma research, 201605– collab new BioMed X research group to discover new treatm options for psychiatric diseases 2016-05-23
MorphoSys–UBS: investor conference, 201605 supply service MorphoSys presents at UBS Global Healthcare Conference NY 2016-05-23
Monsanto–Bayer: investment, 201605– acquisiton unsolicited $66b all-cash offer $128/share by Bayer 2016-05-19
Medigene–BioNTech: cell therapy, 201605– supply + collab process developm to produce TCR-modified T cells by Eufets GmbH 2016-05-18
Bayer–ERS Genomics: CRISPR technology, 201605– license €na to patents for certain cross-divisional applications in Bayer’s core strategic areas 2016-05-17
Boehringer–Max Planck: CNS drug, 201605– Boehringer acquires option for excl rights to new schizophrenia lead compound from LDC 2016-05-11
Apogenix–Informa: investor conference, 201605 supply service Apogenix presents at BioEquity Europe 2016 in Copenhagen 2016-05-10
Bayer–BioNTech: mRNA technology, 201605– collab €na developm mRNA vaccines + therapeutics for animal use 2016-05-10
BioNTech–Bayer: investment, 201605 investment €na by BLSC in connection with animal health mRNA collaboration 2016-05-10
MorphoSys–Goldman Sachs: investor conference, 201605 supply service MorphoSys presents at GS European Small & Mid-Cap Symposium in London 2016-05-10
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2017 Germany May 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2017 Germany May 120x80px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture Berlin Partner HealthCapital Bionnale 2017 Germany May 120x80px